Vicore starts collaboration with Alex Therapeutics to develop new digital therapeutic for patients with IPF
- Webinar will be held today at 15:00 CET (9:00 am EST)
- Digital therapeutics expert Jessica Shull joins Vicore to drive DTx program
News provided by
Share this article
GOTHENBURG, Sweden, May 4, 2021 /PRNewswire/
Vicore Pharma Holding AB (publ) ( Vicore ), a rare disease pharmaceutical company developing innovative medicines for fibrotic lung disorders such as idiopathic pulmonary fibrosis (IPF), today announces the signing of an agreement with Alex Therapeutics AB for the development and clinical validation of a digital therapeutic (DTx) built on the Alex DTx Platform . Vicore will hold a webinar at 15:00 CET (9 AM EST) today to outline the strategic importance and operational details of the new program.
Vicore starts collaboration with Alex Therapeutics to develop new digital therapeutic for patients with IPF
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Vicore starts collaboration with Alex Therapeutics to develop new digital therapeutic for patients with IPF
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
BUTLER â The newly-remodeled media center at Eastside Junior-Senior High School offers an abundance of opportunities.
Students and staff can work in private or have small group meetings, complete with large-screen monitors that can be linked to a computer.
They can move to a larger, enclosed room as a maker space.
They can kick back and relax at one of the padded seats located throughout the center or sit at tables to study or work on homework.
They can enjoy a cup of coffee or drink at the café, named the âBlazer Bean.â
Some students can help a staff member perform repairs on computer equipment for their classmates.